-transparent.png){kind=logo}
The influence of diet on the single-dose pharmacokinetics of isosorbide 5-mononitrate (IS-5-MN) and sustained-release isosorbide dinitrate (ISDN) was studied in 8 healthy male volunteers. The subjects received either a low-calorie/low-fat diet (LCFD) or a high-calorie/high-fat diet (HCFD) according to a cross-over schedule and were administered the drug in tablet form after breakfast. The study was conducted first in 8 subjects who received a 20 mg IS-5-MN tablet and then in 6 of these individuals who received a 20 mg sustained-release ISDN tablet. After oral doses of IS-5-MN, the plasma drug levels declined monoexponentially and could be described by a one-compartment open model. There were no significant differences in the pharmacokinetic parameters for IS-5-MN between the LCFD and the HCFD. After administration of sustained-release ISDN, the plasma ISDN levels showed marked variations both between and within individuals. The increase in the mean AUC0-12 values for ISDN with the HCFD was found to exceed 60%, although there was no significant difference between the two diets.
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
September 1989,
International journal of clinical pharmacology, therapy, and toxicology,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
January 1986,
Pharmatherapeutica,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
May 1984,
British journal of clinical pharmacology,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
January 1987,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
June 1985,
Ugeskrift for laeger,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
April 1981,
Die Medizinische Welt,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
October 1989,
Arzneimittel-Forschung,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
January 1982,
Arzneimittel-Forschung,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
January 1987,
Cardiology,
H Sata, and
K Inoue, and
T Nii, and
T Kuroda
January 1995,
Clinical therapeutics,
